-
Author
Al Hossain, Jubayer 1 Bjerkvig, Rolf 1 Brabek, Jan 1 Daubon, Thomas 1 Enger, Per Øyvind 1 Eskilsson, Eskil 1 Euskirchen, Philipp 1 Foerster, Sarah 1 Folk, Petr 1 Fritah, Sabrina 1 Graziani, Grazia 1 Harter, Patrick N 1 Jahedi, Roza 1 Jirik, Radovan 1 Joseph, Justin V 1 Keunen, Olivier 1 Knappskog, Stian 1 Leiss, Lina 1 Lund-Johansen, Morten 1 Miletic, Hrvoje 1
-
Workplace
Centre for Evolution and Cancer The Institut... 1 Department of Biomedicine University of Berg... 1 Department of Clinical Neurosciences Univers... 1 Department of Clinical Pharmacy Institute of... 1 Department of Clinical Science University of... 1 Department of Experimental Neurology Charité... 1 Department of Neurooncology University Hospi... 1 Department of Neurosurgery Haukeland Univers... 1 Department of Oncology Haukeland University ... 1 Department of Pathology Haukeland University... 1 Department of Physiology and Developmental B... 1 Department of Systems Medicine University of... 1 Edinger Intsitute Goethe University Medical ... 1 INSERM U1029 University of Bordeaux Allée Ge... 1 Institute of Scientific Instruments ASCR Brn... 1 KG Jebsen Brain Tumor Research Center Univer... 1 Neuro Clinic Haukeland University Hospital B... 1 Norlux Neuro Oncology Laboratory Department ... 1 Statistics and Computational Biology Laborat... 1
- Format
- Publication type
- Check Tag
- Category
- Language
- Country
- Journal/source
- Accessibility
- Owner
-
Eskilsson, Eskil
Author Eskilsson, Eskil Department of Biomedicine, University of Bergen, Norway (E.E., G.V.R., K.M.T., O.K., T.T., K.V., J.A.H., J.V.J., R.J., H.S.S., L.L., T.D., P.Ø.E., R.B., H.M.) KG Jebsen Brain Tumor Research Center, University of Bergen, Norway (E.E., G.V.R., K.M.T., O.K., K.V., J.A.H., J.V.J., T.D., P. Ø.E., S.P.N., R.B., H.M.) Department of Clinical Science, University of Bergen, Norway (S.K.) Department of Oncology, Haukeland University Hospital, Bergen, Norway (S.K.) Norlux Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health, Luxembourg (O.K., S.F., S.P.N., R.B.) Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK (A.S.) Department of Clinical Pharmacy, Institute of Pharmacy, Ernst-Moritz-Arndt-University, Greifswald, Germany (S.F., C.A.R.) Department of Neurooncology, University Hospital Heidelberg, Germany (G.S., F.W.) Institute of Scientific Instruments, ASCR, Brno, Czech Republic (R.J.) Edinger-Intsitute, Goethe-University Medical School, Frankfurt am Main, Germany (P.N.H.) Department of Pathology, Haukeland University Hospital, Bergen, Norway (J.A.H., H.M.) Department of Clinical Neurosciences, University of Cambridge, UK (S.G.P., C.W.) Statistics and Computational Biology Laboratory, University of Cambridge, UK (I.S.) Neuro Clinic, Haukeland University Hospital, Bergen, Norway Department of Experimental Neurology, Charité - Universitätsmedizin Berlin, Germany (P.E.) Department of Systems Medicine, University of Rome «Tor Vergata», Rome, Italy (G.G.) INSERM U1029 - University of Bordeaux, Allée Geoffroy St. Hilaire, Pessac, France (T.D.) Department of Neurosurgery, Haukeland University Hospital, Bergen, Norway (M.L.-J., P. Ø.E.)
-
Rosland, Gro V
Author Rosland, Gro V Department of Biomedicine, University of Bergen, Norway (E.E., G.V.R., K.M.T., O.K., T.T., K.V., J.A.H., J.V.J., R.J., H.S.S., L.L., T.D., P.Ø.E., R.B., H.M.) KG Jebsen Brain Tumor Research Center, University of Bergen, Norway (E.E., G.V.R., K.M.T., O.K., K.V., J.A.H., J.V.J., T.D., P. Ø.E., S.P.N., R.B., H.M.) Department of Clinical Science, University of Bergen, Norway (S.K.) Department of Oncology, Haukeland University Hospital, Bergen, Norway (S.K.) Norlux Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health, Luxembourg (O.K., S.F., S.P.N., R.B.) Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK (A.S.) Department of Clinical Pharmacy, Institute of Pharmacy, Ernst-Moritz-Arndt-University, Greifswald, Germany (S.F., C.A.R.) Department of Neurooncology, University Hospital Heidelberg, Germany (G.S., F.W.) Institute of Scientific Instruments, ASCR, Brno, Czech Republic (R.J.) Edinger-Intsitute, Goethe-University Medical School, Frankfurt am Main, Germany (P.N.H.) Department of Pathology, Haukeland University Hospital, Bergen, Norway (J.A.H., H.M.) Department of Clinical Neurosciences, University of Cambridge, UK (S.G.P., C.W.) Statistics and Computational Biology Laboratory, University of Cambridge, UK (I.S.) Neuro Clinic, Haukeland University Hospital, Bergen, Norway Department of Experimental Neurology, Charité - Universitätsmedizin Berlin, Germany (P.E.) Department of Systems Medicine, University of Rome «Tor Vergata», Rome, Italy (G.G.) INSERM U1029 - University of Bordeaux, Allée Geoffroy St. Hilaire, Pessac, France (T.D.) Department of Neurosurgery, Haukeland University Hospital, Bergen, Norway (M.L.-J., P. Ø.E.)
-
Talasila, Krishna M
Author Talasila, Krishna M Department of Biomedicine, University of Bergen, Norway (E.E., G.V.R., K.M.T., O.K., T.T., K.V., J.A.H., J.V.J., R.J., H.S.S., L.L., T.D., P.Ø.E., R.B., H.M.) KG Jebsen Brain Tumor Research Center, University of Bergen, Norway (E.E., G.V.R., K.M.T., O.K., K.V., J.A.H., J.V.J., T.D., P. Ø.E., S.P.N., R.B., H.M.) Department of Clinical Science, University of Bergen, Norway (S.K.) Department of Oncology, Haukeland University Hospital, Bergen, Norway (S.K.) Norlux Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health, Luxembourg (O.K., S.F., S.P.N., R.B.) Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK (A.S.) Department of Clinical Pharmacy, Institute of Pharmacy, Ernst-Moritz-Arndt-University, Greifswald, Germany (S.F., C.A.R.) Department of Neurooncology, University Hospital Heidelberg, Germany (G.S., F.W.) Institute of Scientific Instruments, ASCR, Brno, Czech Republic (R.J.) Edinger-Intsitute, Goethe-University Medical School, Frankfurt am Main, Germany (P.N.H.) Department of Pathology, Haukeland University Hospital, Bergen, Norway (J.A.H., H.M.) Department of Clinical Neurosciences, University of Cambridge, UK (S.G.P., C.W.) Statistics and Computational Biology Laboratory, University of Cambridge, UK (I.S.) Neuro Clinic, Haukeland University Hospital, Bergen, Norway Department of Experimental Neurology, Charité - Universitätsmedizin Berlin, Germany (P.E.) Department of Systems Medicine, University of Rome «Tor Vergata», Rome, Italy (G.G.) INSERM U1029 - University of Bordeaux, Allée Geoffroy St. Hilaire, Pessac, France (T.D.) Department of Neurosurgery, Haukeland University Hospital, Bergen, Norway (M.L.-J., P. Ø.E.)
-
Knappskog, Stian
Author Knappskog, Stian Department of Biomedicine, University of Bergen, Norway (E.E., G.V.R., K.M.T., O.K., T.T., K.V., J.A.H., J.V.J., R.J., H.S.S., L.L., T.D., P.Ø.E., R.B., H.M.) KG Jebsen Brain Tumor Research Center, University of Bergen, Norway (E.E., G.V.R., K.M.T., O.K., K.V., J.A.H., J.V.J., T.D., P. Ø.E., S.P.N., R.B., H.M.) Department of Clinical Science, University of Bergen, Norway (S.K.) Department of Oncology, Haukeland University Hospital, Bergen, Norway (S.K.) Norlux Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health, Luxembourg (O.K., S.F., S.P.N., R.B.) Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK (A.S.) Department of Clinical Pharmacy, Institute of Pharmacy, Ernst-Moritz-Arndt-University, Greifswald, Germany (S.F., C.A.R.) Department of Neurooncology, University Hospital Heidelberg, Germany (G.S., F.W.) Institute of Scientific Instruments, ASCR, Brno, Czech Republic (R.J.) Edinger-Intsitute, Goethe-University Medical School, Frankfurt am Main, Germany (P.N.H.) Department of Pathology, Haukeland University Hospital, Bergen, Norway (J.A.H., H.M.) Department of Clinical Neurosciences, University of Cambridge, UK (S.G.P., C.W.) Statistics and Computational Biology Laboratory, University of Cambridge, UK (I.S.) Neuro Clinic, Haukeland University Hospital, Bergen, Norway Department of Experimental Neurology, Charité - Universitätsmedizin Berlin, Germany (P.E.) Department of Systems Medicine, University of Rome «Tor Vergata», Rome, Italy (G.G.) INSERM U1029 - University of Bordeaux, Allée Geoffroy St. Hilaire, Pessac, France (T.D.) Department of Neurosurgery, Haukeland University Hospital, Bergen, Norway (M.L.-J., P. Ø.E.)
-
Keunen, Olivier
Author Keunen, Olivier Department of Biomedicine, University of Bergen, Norway (E.E., G.V.R., K.M.T., O.K., T.T., K.V., J.A.H., J.V.J., R.J., H.S.S., L.L., T.D., P.Ø.E., R.B., H.M.) KG Jebsen Brain Tumor Research Center, University of Bergen, Norway (E.E., G.V.R., K.M.T., O.K., K.V., J.A.H., J.V.J., T.D., P. Ø.E., S.P.N., R.B., H.M.) Department of Clinical Science, University of Bergen, Norway (S.K.) Department of Oncology, Haukeland University Hospital, Bergen, Norway (S.K.) Norlux Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health, Luxembourg (O.K., S.F., S.P.N., R.B.) Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK (A.S.) Department of Clinical Pharmacy, Institute of Pharmacy, Ernst-Moritz-Arndt-University, Greifswald, Germany (S.F., C.A.R.) Department of Neurooncology, University Hospital Heidelberg, Germany (G.S., F.W.) Institute of Scientific Instruments, ASCR, Brno, Czech Republic (R.J.) Edinger-Intsitute, Goethe-University Medical School, Frankfurt am Main, Germany (P.N.H.) Department of Pathology, Haukeland University Hospital, Bergen, Norway (J.A.H., H.M.) Department of Clinical Neurosciences, University of Cambridge, UK (S.G.P., C.W.) Statistics and Computational Biology Laboratory, University of Cambridge, UK (I.S.) Neuro Clinic, Haukeland University Hospital, Bergen, Norway Department of Experimental Neurology, Charité - Universitätsmedizin Berlin, Germany (P.E.) Department of Systems Medicine, University of Rome «Tor Vergata», Rome, Italy (G.G.) INSERM U1029 - University of Bordeaux, Allée Geoffroy St. Hilaire, Pessac, France (T.D.) Department of Neurosurgery, Haukeland University Hospital, Bergen, Norway (M.L.-J., P. Ø.E.)
-
Sottoriva, Andrea
Author Sottoriva, Andrea Department of Biomedicine, University of Bergen, Norway (E.E., G.V.R., K.M.T., O.K., T.T., K.V., J.A.H., J.V.J., R.J., H.S.S., L.L., T.D., P.Ø.E., R.B., H.M.) KG Jebsen Brain Tumor Research Center, University of Bergen, Norway (E.E., G.V.R., K.M.T., O.K., K.V., J.A.H., J.V.J., T.D., P. Ø.E., S.P.N., R.B., H.M.) Department of Clinical Science, University of Bergen, Norway (S.K.) Department of Oncology, Haukeland University Hospital, Bergen, Norway (S.K.) Norlux Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health, Luxembourg (O.K., S.F., S.P.N., R.B.) Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK (A.S.) Department of Clinical Pharmacy, Institute of Pharmacy, Ernst-Moritz-Arndt-University, Greifswald, Germany (S.F., C.A.R.) Department of Neurooncology, University Hospital Heidelberg, Germany (G.S., F.W.) Institute of Scientific Instruments, ASCR, Brno, Czech Republic (R.J.) Edinger-Intsitute, Goethe-University Medical School, Frankfurt am Main, Germany (P.N.H.) Department of Pathology, Haukeland University Hospital, Bergen, Norway (J.A.H., H.M.) Department of Clinical Neurosciences, University of Cambridge, UK (S.G.P., C.W.) Statistics and Computational Biology Laboratory, University of Cambridge, UK (I.S.) Neuro Clinic, Haukeland University Hospital, Bergen, Norway Department of Experimental Neurology, Charité - Universitätsmedizin Berlin, Germany (P.E.) Department of Systems Medicine, University of Rome «Tor Vergata», Rome, Italy (G.G.) INSERM U1029 - University of Bordeaux, Allée Geoffroy St. Hilaire, Pessac, France (T.D.) Department of Neurosurgery, Haukeland University Hospital, Bergen, Norway (M.L.-J., P. Ø.E.)
-
Foerster, Sarah
Author Foerster, Sarah Department of Biomedicine, University of Bergen, Norway (E.E., G.V.R., K.M.T., O.K., T.T., K.V., J.A.H., J.V.J., R.J., H.S.S., L.L., T.D., P.Ø.E., R.B., H.M.) KG Jebsen Brain Tumor Research Center, University of Bergen, Norway (E.E., G.V.R., K.M.T., O.K., K.V., J.A.H., J.V.J., T.D., P. Ø.E., S.P.N., R.B., H.M.) Department of Clinical Science, University of Bergen, Norway (S.K.) Department of Oncology, Haukeland University Hospital, Bergen, Norway (S.K.) Norlux Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health, Luxembourg (O.K., S.F., S.P.N., R.B.) Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK (A.S.) Department of Clinical Pharmacy, Institute of Pharmacy, Ernst-Moritz-Arndt-University, Greifswald, Germany (S.F., C.A.R.) Department of Neurooncology, University Hospital Heidelberg, Germany (G.S., F.W.) Institute of Scientific Instruments, ASCR, Brno, Czech Republic (R.J.) Edinger-Intsitute, Goethe-University Medical School, Frankfurt am Main, Germany (P.N.H.) Department of Pathology, Haukeland University Hospital, Bergen, Norway (J.A.H., H.M.) Department of Clinical Neurosciences, University of Cambridge, UK (S.G.P., C.W.) Statistics and Computational Biology Laboratory, University of Cambridge, UK (I.S.) Neuro Clinic, Haukeland University Hospital, Bergen, Norway Department of Experimental Neurology, Charité - Universitätsmedizin Berlin, Germany (P.E.) Department of Systems Medicine, University of Rome «Tor Vergata», Rome, Italy (G.G.) INSERM U1029 - University of Bordeaux, Allée Geoffroy St. Hilaire, Pessac, France (T.D.) Department of Neurosurgery, Haukeland University Hospital, Bergen, Norway (M.L.-J., P. Ø.E.)
-
Solecki, Gergely
Author Solecki, Gergely Department of Biomedicine, University of Bergen, Norway (E.E., G.V.R., K.M.T., O.K., T.T., K.V., J.A.H., J.V.J., R.J., H.S.S., L.L., T.D., P.Ø.E., R.B., H.M.) KG Jebsen Brain Tumor Research Center, University of Bergen, Norway (E.E., G.V.R., K.M.T., O.K., K.V., J.A.H., J.V.J., T.D., P. Ø.E., S.P.N., R.B., H.M.) Department of Clinical Science, University of Bergen, Norway (S.K.) Department of Oncology, Haukeland University Hospital, Bergen, Norway (S.K.) Norlux Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health, Luxembourg (O.K., S.F., S.P.N., R.B.) Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK (A.S.) Department of Clinical Pharmacy, Institute of Pharmacy, Ernst-Moritz-Arndt-University, Greifswald, Germany (S.F., C.A.R.) Department of Neurooncology, University Hospital Heidelberg, Germany (G.S., F.W.) Institute of Scientific Instruments, ASCR, Brno, Czech Republic (R.J.) Edinger-Intsitute, Goethe-University Medical School, Frankfurt am Main, Germany (P.N.H.) Department of Pathology, Haukeland University Hospital, Bergen, Norway (J.A.H., H.M.) Department of Clinical Neurosciences, University of Cambridge, UK (S.G.P., C.W.) Statistics and Computational Biology Laboratory, University of Cambridge, UK (I.S.) Neuro Clinic, Haukeland University Hospital, Bergen, Norway Department of Experimental Neurology, Charité - Universitätsmedizin Berlin, Germany (P.E.) Department of Systems Medicine, University of Rome «Tor Vergata», Rome, Italy (G.G.) INSERM U1029 - University of Bordeaux, Allée Geoffroy St. Hilaire, Pessac, France (T.D.) Department of Neurosurgery, Haukeland University Hospital, Bergen, Norway (M.L.-J., P. Ø.E.)
-
Taxt, Torfinn
Author Taxt, Torfinn Department of Biomedicine, University of Bergen, Norway (E.E., G.V.R., K.M.T., O.K., T.T., K.V., J.A.H., J.V.J., R.J., H.S.S., L.L., T.D., P.Ø.E., R.B., H.M.) KG Jebsen Brain Tumor Research Center, University of Bergen, Norway (E.E., G.V.R., K.M.T., O.K., K.V., J.A.H., J.V.J., T.D., P. Ø.E., S.P.N., R.B., H.M.) Department of Clinical Science, University of Bergen, Norway (S.K.) Department of Oncology, Haukeland University Hospital, Bergen, Norway (S.K.) Norlux Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health, Luxembourg (O.K., S.F., S.P.N., R.B.) Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK (A.S.) Department of Clinical Pharmacy, Institute of Pharmacy, Ernst-Moritz-Arndt-University, Greifswald, Germany (S.F., C.A.R.) Department of Neurooncology, University Hospital Heidelberg, Germany (G.S., F.W.) Institute of Scientific Instruments, ASCR, Brno, Czech Republic (R.J.) Edinger-Intsitute, Goethe-University Medical School, Frankfurt am Main, Germany (P.N.H.) Department of Pathology, Haukeland University Hospital, Bergen, Norway (J.A.H., H.M.) Department of Clinical Neurosciences, University of Cambridge, UK (S.G.P., C.W.) Statistics and Computational Biology Laboratory, University of Cambridge, UK (I.S.) Neuro Clinic, Haukeland University Hospital, Bergen, Norway Department of Experimental Neurology, Charité - Universitätsmedizin Berlin, Germany (P.E.) Department of Systems Medicine, University of Rome «Tor Vergata», Rome, Italy (G.G.) INSERM U1029 - University of Bordeaux, Allée Geoffroy St. Hilaire, Pessac, France (T.D.) Department of Neurosurgery, Haukeland University Hospital, Bergen, Norway (M.L.-J., P. Ø.E.)
-
Jirik, Radovan
Author Jirik, Radovan Department of Biomedicine, University of Bergen, Norway (E.E., G.V.R., K.M.T., O.K., T.T., K.V., J.A.H., J.V.J., R.J., H.S.S., L.L., T.D., P.Ø.E., R.B., H.M.) KG Jebsen Brain Tumor Research Center, University of Bergen, Norway (E.E., G.V.R., K.M.T., O.K., K.V., J.A.H., J.V.J., T.D., P. Ø.E., S.P.N., R.B., H.M.) Department of Clinical Science, University of Bergen, Norway (S.K.) Department of Oncology, Haukeland University Hospital, Bergen, Norway (S.K.) Norlux Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health, Luxembourg (O.K., S.F., S.P.N., R.B.) Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK (A.S.) Department of Clinical Pharmacy, Institute of Pharmacy, Ernst-Moritz-Arndt-University, Greifswald, Germany (S.F., C.A.R.) Department of Neurooncology, University Hospital Heidelberg, Germany (G.S., F.W.) Institute of Scientific Instruments, ASCR, Brno, Czech Republic (R.J.) Edinger-Intsitute, Goethe-University Medical School, Frankfurt am Main, Germany (P.N.H.) Department of Pathology, Haukeland University Hospital, Bergen, Norway (J.A.H., H.M.) Department of Clinical Neurosciences, University of Cambridge, UK (S.G.P., C.W.) Statistics and Computational Biology Laboratory, University of Cambridge, UK (I.S.) Neuro Clinic, Haukeland University Hospital, Bergen, Norway Department of Experimental Neurology, Charité - Universitätsmedizin Berlin, Germany (P.E.) Department of Systems Medicine, University of Rome «Tor Vergata», Rome, Italy (G.G.) INSERM U1029 - University of Bordeaux, Allée Geoffroy St. Hilaire, Pessac, France (T.D.) Department of Neurosurgery, Haukeland University Hospital, Bergen, Norway (M.L.-J., P. Ø.E.)
NLK
Free Medical Journals
from 1999 to 1 year ago
PubMed Central
from 1999 to 1 year ago
Europe PubMed Central
from 1999 to 1 year ago
Open Access Digital Library
from 1999-01-01
Medline Complete (EBSCOhost)
from 2004-01-01 to 1 year ago
PubMed
27286795
DOI
10.1093/neuonc/now113
Knihovny.cz E-resources
BACKGROUND: Amplification of the epidermal growth factor receptor (EGFR) and its mutant EGFRvIII are among the most common genetic alterations in glioblastoma (GBM), the most frequent and most aggressive primary brain tumor. METHODS: In the present work, we analyzed the clonal evolution of these major EGFR aberrations in a small cohort of GBM patients using a unique surgical multisampling technique. Furthermore, we overexpressed both receptors separately and together in 2 patient-derived GBM stem cell lines (GSCs) to analyze their functions in vivo in orthotopic xenograft models. RESULTS: In human GBM biopsies, we identified EGFR amplification as an early event because EGFRvIII mutations emerge from intratumoral heterogeneity later in tumor development. To investigate the biological relevance of this distinct developmental pattern, we established experimental model systems. In these models, EGFR(+) tumor cells showed activation of classical downstream signaling pathways upon EGF stimulation and displayed enhanced invasive growth without evidence of angiogenesis in vivo. In contrast, EGFRvIII(+) tumors were driven by activation of the prototypical Src family kinase c-Src that promoted VEGF secretion leading to angiogenic tumor growth. CONCLUSIONS: The presented work shows that sequential EGFR amplification and EGFRvIII mutations might represent concerted evolutionary events that drive the aggressive nature of GBM by promoting invasion and angiogenesis via distinct signaling pathways. In particular, c-SRC may be an attractive therapeutic target for tumors harboring EGFRvIII as we identified this protein specifically mediating angiogenic tumor growth downstream of EGFRvIII.
- MeSH
- Survival Analysis MeSH
- ErbB Receptors genetics metabolism MeSH
- Glioblastoma diagnostic imaging genetics metabolism pathology MeSH
- Neoplasm Invasiveness MeSH
- Humans MeSH
- Evolution, Molecular MeSH
- Brain diagnostic imaging pathology MeSH
- Multimodal Imaging MeSH
- Mutation MeSH
- Cell Line, Tumor MeSH
- Brain Neoplasms diagnostic imaging genetics metabolism pathology MeSH
- Neovascularization, Pathologic metabolism MeSH
- Proto-Oncogene Proteins pp60(c-src) metabolism MeSH
- Up-Regulation MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
NLK
ScienceDirect (archiv)
from 1993-01-01 to 2009-12-31
PubMed
12176033
DOI
10.1016/s0006-291x(02)00884-7
Knihovny.cz E-resources
Share
Document title
The link will be redirected to the address of the production version after the testing phase.